Cart
sales@molnova.com
TWS119
CAS No. 601514-19-6
TWS119( TWS 119 | TWS-119 )
Catalog No. M15239 CAS No. 601514-19-6
A GSK-3β inhibitor with IC50 of 30 nM in a cell-free assay; can induce neurogenesis in murine ESCs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 45 | In Stock |
|
| 5MG | 41 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 130 | In Stock |
|
| 50MG | 235 | In Stock |
|
| 100MG | 406 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTWS119
-
NoteResearch use only, not for human use.
-
Brief DescriptionA GSK-3β inhibitor with IC50 of 30 nM in a cell-free assay; can induce neurogenesis in murine ESCs.
-
DescriptionA GSK-3β inhibitor with IC50 of 30 nM in a cell-free assay; can induce neurogenesis in murine ESCs; reduces Cdon levels and aberrant Cx43 activitiesin rat cardiomyocytes; attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
-
In Vitro——
-
In Vivo——
-
SynonymsTWS 119 | TWS-119
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3β
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number601514-19-6
-
Formula Weight318.3293
-
Molecular FormulaC18H14N4O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O
-
Chemical NamePhenol, 3-[[6-(3-aminophenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ding S, et al. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7632-7.
2. Wang W, et al. Mol Neurobiol. 2016 Dec;53(10):7028-7036.
3. Jeong MH, et al. Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1345-E1354.
molnova catalog
related products
-
5-Iodo-indirubin-3-m...
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase (IC50s: 9, 20 and 25 nM).
-
CDK8-IN-12
CDK8-IN-12 is a selective, potent and orally active inhibitor of CDK8 (Ki: 14 nM) and is an anti-cancer agent.
-
Tideglusib
Tideglusib is an irreversible, non ATP-competitive GSK-3β inhibitor with IC50 of 60 nM in a cell-free assay.
